FindTrial
Sign In

TO STUDY THE EFFECT OF VARMAM AND SIDDHA TRIAL DRUGS â??NILAVAAGAI KIYAZHAMâ??(Internal) , â??KAAL VARMA THAILAMâ??(External) IN PATIENT WITH AZHAL KEEL VAAYU (OSTEOARTHRITIS)

PHASE II NON RANDOMIZED OPEN COMPARATIVE CLINICAL EVALUATION OF VARMAM AND SIDDHA TRIAL DRUGS â??NILAVAAGAI KIYAZHAMâ?? , â??KAAL VARMA THAILAMâ?? ON AZHAL KEEL VAAYU (OSTEOARTHRITIS) IN PATIENT ATTENDING OPD AT VARMAM DEPARTMENT OF ARINGNAR ANNA HOSPITAL.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019525
Enrollment
60
Registered
2019-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M17- Osteoarthritis of knee

Interventions

Intervention1: Nilavaagai kiyazham (internal) and Kaal varma thailam (external): 265 ml of Nilavaagai kiyazham given twice a day before a meal for 5 days in 3 cycles with a gap of 5 days in between ea

Sponsors

Aringer Anna Goverment Siddha Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Knee pain for most days of the prior month, Crepitus on active joint motion, Morning stiffness equal and not more than 30 minutes in duration, Restricted movements.

Exclusion criteria

Exclusion criteria: Trauma, Metabolic arthritis, Autoimmune arthritis, Reactive arthritis, Haemophilic arthritis, Psoriatic arthritis, Ligament injury, Infectious arthritis, HIV, Hypertension, Diabetes Mellitus, Pregnancy & lactation.

Design outcomes

Primary

MeasureTime frame
Pain reduction is evidenced by pain assessment scale(visual analogue scale) and WOMAC SCALE.Timepoint: 25 days.—

Secondary

MeasureTime frame
Secondary outcome is assessed by comparing the safety parameters before and after treatment.Timepoint: Nil—

Countries

India

Contacts

Public ContactDr T R Siddique Ali

Goverment Siddha Medical College

tkrsiddique@gmail.com9962019900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026